Veol Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 0.83 M
as on 03-07-2024
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.80 Cr
as on 03-07-2024
- Revenue 47.03%
(FY 2023)
- Profit 91.47%
(FY 2023)
- Ebitda 226.63%
(FY 2023)
- Net Worth 25.61%
(FY 2023)
- Total Assets 26.02%
(FY 2023)
About Veol Medical Technologies
The Corporate was formerly known as Veol Labs Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.83 M.
The company currently has active open charges totaling ₹1.80 Cr.
Mangesh Patankar, Shruti Kumari, and Manoj Kurlekar serve as directors at the Company.
- CIN/LLPIN
U73100MH2008PTC187836
- Company No.
187836
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2008
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Veol Medical Technologies Private Limited offer?
Veol Medical Technologies Private Limited offers a wide range of products and services, including Laparoscopic Instruments, Morcellator, Pharma & Bioanalytical Services, Pharmaceutical Services, Bulk Bags & Sacks, Garbage and Waste Bags, Surgical Needles, Aspiration Needles.
Who are the key members and board of directors at Veol Medical Technologies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mangesh Patankar  | Managing Director | 07-Sep-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shruti Kumari | Director | 09-Apr-2016 | Current |
| Manoj Kurlekar | Director | 06-Sep-2019 | Current |
Financial Performance of Veol Medical Technologies.
Veol Medical Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 47.03% increase. The company also saw a substantial improvement in profitability, with a 91.47% increase in profit. The company's net worth Soared by an impressive increase of 25.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Veol Medical Technologies?
In 2023, Veol Medical Technologies had a promoter holding of 52.11% and a public holding of 47.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Aug 2016 | ₹9.00 M | Open |
Hdfc Bank Limited Creation Date: 11 Nov 2010 | ₹9.00 M | Open |
How Many Employees Work at Veol Medical Technologies?
Veol Medical Technologies has a workforce of 82 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Veol Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Veol Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
